
Portal Instruments
Total Raised
$49.68MInvestors Count
4Deal Terms
2Funding, Valuation & Revenue
5 Fundings
Portal Instruments has raised $49.68M over 5 rounds.
Portal Instruments's latest funding round was a Series C for $7M on April 29, 2022.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
4/29/2022 | Series C | $7M | 5AM Ventures, and PBJ Capital | 1 | ||
4/28/2020 | Loan | |||||
10/20/2017 | Series B - III | |||||
10/20/2015 | Series B | |||||
10/15/2014 | Series A |
Date | 4/29/2022 | 4/28/2020 | 10/20/2017 | 10/20/2015 | 10/15/2014 |
|---|---|---|---|---|---|
Round | Series C | Loan | Series B - III | Series B | Series A |
Amount | $7M | ||||
Investors | 5AM Ventures, and PBJ Capital | ||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
Portal Instruments Deal Terms
2 Deal Terms
Portal Instruments's deal structure is available for 2 funding rounds, including their Series B from October 20, 2015.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Portal Instruments Investors
4 Investors
Portal Instruments has 4 investors. 5AM Ventures invested in Portal Instruments's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/20/2015 | 4/29/2022 | 3 Series B, Series B - III (2017), Series C (2022) | Venture Capital | California | ||
Venture Capital | Massachusetts | |||||
Government | DC | |||||
Corporation | France |
First funding | 10/20/2015 | |||
|---|---|---|---|---|
Last Funding | 4/29/2022 | |||
Investor | ||||
Rounds | 3 Series B, Series B - III (2017), Series C (2022) | |||
Board Seats | ||||
Type | Venture Capital | Venture Capital | Government | Corporation |
Location | California | Massachusetts | DC | France |
Compare Portal Instruments to Competitors
R4 Vascular focuses on the design and manufacturing of vascular access products within the medical device industry. The company provides products that enable access to patient vasculature for the delivery of chemotherapy, blood products, antibiotics, drugs, or nutrition, primarily used by clinicians including oncologists, interventional radiologists, surgeons, and nurses. It is based in Hoboken, New Jersey.

Ever Health provides telemedicine services in the healthcare technology sector. The company has a telemedicine platform that includes digital consultations and remote diagnostics. Ever Health serves various sectors including enterprises, insurance companies, educational institutions, healthcare professionals, and senior care services. It was founded in 2013 and is based in Madrid, Spain.
Subcuject is a medical device company focused on developing drug delivery systems within the healthcare sector. Their main offerings include a Wearable Bolus Injector (WBI) that uses osmosis to facilitate subcutaneous injection of larger pharmaceutical volumes, and a Hands-Free Autoinjector aimed at patients with dexterity challenges. These devices are prefilled, feature automatic needle insertion and retraction, and are intended to work with pharmaceutical development processes. It is based in Hellebaek, Denmark.

Crossject Medical Technology is a pharmaceutical company that develops needle-free auto-injectors for emergency situations. The company's main product, ZENEO4, is a pre-filled, single-use auto-injector designed for the delivery of emergency medications without needles. Crossject serves the healthcare sector, offering solutions for conditions such as epilepsy, allergic shocks, and adrenal insufficiencies. It was founded in 2001 and is based in France.
Iaculor Injection Inc. develops low-cost, more efficient needle-free injection devices that allow the delivery of powder or liquid forms of vaccines, small molecules, and biologicals.
Depotech is developing methods for drug delivery
Loading...

